Interleukin enhancer-binding factor 3 (ILF3) (AA 785-894) antibody
Quick Overview for Interleukin enhancer-binding factor 3 (ILF3) (AA 785-894) antibody (ABIN7156720)
Target
See all Interleukin enhancer-binding factor 3 (ILF3) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 785-894
-
Cross-Reactivity
- Human
-
Purification
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human Interleukin enhancer-binding factor 3 protein (785-894AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: WB:1:200-1:1000, IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Interleukin enhancer-binding factor 3 (ILF3)
-
Alternative Name
- ILF3
-
Background
-
Background: May facilitate double-stranded RNA-regulated gene expression at the level of post-transcription. Can act as a translation inhibitory protein which binds to coding sequences of acid beta-glucosidase (GCase) and other mRNAs and functions at the initiation phase of GCase mRNA translation, probably by inhibiting its binding to polysomes. Can regulate protein arginine N-methyltransferase 1 activity. May regulate transcription of the IL2 gene during T-cell activation. Can promote the formation of stable DNA-dependent protein kinase holoenzyme complexes on DNA. The phosphorylated form at Thr-188 and Thr-315, in concert with EIF2AK2/PKR can inhibit vesicular stomatitis virus (VSV) replication (By similarity).
Aliases: CBTF antibody, Double stranded RNA binding protein 76 antibody, Double-stranded RNA-binding protein 76 antibody, DRBF antibody, DRBP76 antibody, ILF3 antibody, ILF3_HUMAN antibody, Interleukin enhancer binding factor 3 antibody, Interleukin enhancer-binding factor 3 antibody, M phase phosphoprotein 4 antibody, M-phase phosphoprotein 4 antibody, MPHOSPH4 antibody, MPP4 antibody, NF AT 90 antibody, NF-AT-90 antibody, NF110 antibody, NF90 antibody, NFAR antibody, Nuclear factor associated with dsRNA antibody, Nuclear factor of activated T cells 90 kDa antibody, Nuclear factor of activated T-cells 90 kDa antibody, TCP80 antibody, Translational control protein 80 antibody
-
UniProt
- Q12906
-
Pathways
- M Phase
Target
-